GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » High Sierra Technologies Inc (OTCPK:HSTI) » Definitions » Valuation Rank

High Sierra Technologies (High Sierra Technologies) Valuation Rank


View and export this data going back to . Start your Free Trial

What is High Sierra Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

High Sierra Technologies Valuation Rank Related Terms

Thank you for viewing the detailed overview of High Sierra Technologies's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

High Sierra Technologies (High Sierra Technologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » High Sierra Technologies Inc (OTCPK:HSTI) » Definitions » Valuation Rank
Comparable Companies
ETST TXMD HYEXD INIS ACOR CPIX RAPH QLI DRRX AYTU ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
N/A
Address
1495 Ridgeview Drive, Suite 230A, Reno, NV, USA, 89519
Website
https://www.high-sierra.com
High Sierra Technologies Inc is a start-up that develops and expands its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry. The company owns two provisional patent applications for the production of new and novel cannabis products.
Executives
Jeffrey M. Pogol officer: Vice President 17160 SNOWBERRY DRIVE, RENO NV 89511
Michael Vardakis director, 10 percent owner, officer: President 234 7TH AVE, SALT LAKE CITY UT 84103
Gregg William Koechlein 10 percent owner, officer: CFO, COO, Secretary and Treasu 2560 GREENSBORO DRIVE, RENO NV 89509
Melissa Ladakis director, officer: Secretary/Treasurer 1396 MICHIGAN AVENUE, SALT LAKE CITY UT 84105
Vincent Lombardi 10 percent owner 979 WESTCLIFF LANE, RENO NV 89523